Body Supplements Sarm Steroids Lgd 4033 Ligandrol 1165910-22-4 Androgen Receptor Powder
|FOB Price:||US $1 / g|
|Min. Order:||10 g|
|Min. Order||FOB Price|
|10 g||US $1/ g|
|Production Capacity:||100 Kilogram/Month|
|Payment Terms:||T/T, Western Union, Paypal, Money Gram, Bitcoin|
- Model NO.: cas 1165910-22-4
- Customized: Non-Customized
- Suitable for: Adult
- Purity: >99%
- Transport Package: Discreet Disguised Package
- Origin: China
- Powder: Yes
- Certification: GMP, ISO 9001, USP, BP
- State: Powder
- Trademark: LSW
- Specification: GMP, SGS, BV
- HS Code: 000000
|Product categories||SARMs(Selective androgen receptor modulator)|
|Appearance||White crystalline powder|
|LGD-4033 Usage||A Potent, Non-Steroidal Bodybuilding Supplement|
LGD-4033 is a selective androgen receptor modulator (SARMS), and a novel non-steroidal oral
SARM that binds to AR with high affinity (Ki of ~1 nM) and selectivity. It's in a class of
androgen receptor (AR) ligands that is tissue selective, developed to treat muscle wasting
associated with cancer, acute and chronic illness and age-related muscle loss. LGD-4033
is expected to produce the therapeutic benefits of testosterone with improved safety, tolerability
and patient acceptance due to tissue-selective mechanism of action and an oral route of
LGD-4033, a novel nonsteroidal, oral selective androgen receptor modulator, binds to the
androgen receptor with high affinity and selectivity. It demonstrates anabolic activity in muscles,
anti-resorptive anabolic activity in bones and a robust selectivity for muscle and bone versus
prostate and sebaceous glands. LGD-4033 has recently completed a Phase I Multiple
Ascending Dose study in healthy volunteers. This randomized, double-blind, placebo-controlled
Phase I study established the safety and tolerability up to doses of 22 mg per day.
LGD is still fairly new (3-5 years), but the results have been very similar in studies and logs.
LGD-4033 has undergone several recent studies and trials to find the best and safest way
to use it. From these trials, the results have shown increases in lean body mass and decreases in body fat. There is also a significant increase in strength, well being, as well as healing
LGD has shown the most ability of any SARM to put on size that could be considered a bulk. This will, of course, be dependent upon the diet used. Users that have experienced more than 10lb. increases, and have had a significant increase in calorie intake. The possibility of this
type of size is present with LGD use. A recommend dosage for this type of goal would be 5-10 mg day for 8 weeks.
LGD seems to shine with this method. Many have seen an increase in lean body mass and a decrease
in body fat. LGD seems to work the best with this method. Ran in conjunction with other SARMS, like
cardarine (GW-501516), will only increase the likelihood of a stronger recomp.Recommended
doses for recomping would be 5-8 mg a day for 8 weeks.
LGD can be used to cut as well. It will shine more-so if ran in conjunction with SARMS S4
and Cardarine (GW-501516). This would be similar to a SARMS triple stack that is normally
ran with Ostarine, except there is a possibility of more size being put on while cutting. A good dose for this method would be 3-5 mg a day for 8 weeks.
|Description||White crystalline powder||Conforms|
|HNMR||H group on the peak of the correct attribution||Conforms|
|Loss on drying||Not more than 0.5%||0.3%|
|Heavy metals||Not more than 10ppm||Conforms|
|Conclusion : Compliance with the requirements|
|Product name||CAS No.||Specification|
|AICAR||2627-69-2||acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown|
|MK2866||841205-47-8||medical prescription for prevention of cachexia, atrophy, and sarcopenia and for Hormone or Testoserone Replacement Therapy.|
|MK-677||15972-10-0||A growth hormone secretagogue, treatment of obesity, a promising therapy for the treatment of frailty in the elderly|
|LGD-4033||1165910-22-4||pharmacological profile similar to that of enobosarm, Ostarine,MK-2866|
|GW1516||317318-70-0||For obesity, diabetes, dyslipidemia and cardiovascular disease|
|Andarine(S4)||401900-40-0||partial agonist, intended mainly for treatment of benign prostatic hypertrophy|
|SR9009||1379686-30-2||under development at The Scripps Research Institute (TSRI), increases the level of metabolic activity in skeletal muscles of mice|
|RAD140||1182367-47-0||New generation for gaining mass and cutting edges|
|YK11||431579-34-9||YK11: a SARM and myostatin inhibitor in one|
1. High quality products with competitive prices.
2. Pofessional services are provided.
3. Enough stock and Fast delivery.
4. We asure safe and effective shipping method.
5. Discreet package in unique packing ways.
6. Fast response to any emails or problems.